School of Medicine
Showing 3,061-3,080 of 13,033 Results
-
Mo Esfahanian, MD, D. ABA, FAAP
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMy current interests include investigating the role of regional anesthesia to enhance postoperative recovery in pediatrics, including the suprazygomatic maxillary nerve block for cleft palate surgery, and the external oblique intercostal plane block for first stage microtia repair.
-
Rahim Esfandyarpour
Student, Biochemistry - Genome Center
BioRahim Esfandyarpour received his M.Sc. and Ph.D. in Electrical Engineering from Stanford University in 2010 and 2014 respectively.
-
Neir Eshel, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioDr. Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.
His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the Stanford LGBTQ+ program.
His research interests (www.staarlab.com) include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He has won multi-year grants from the National Institutes of Health, Burroughs-Wellcome Fund, One Mind Foundation, Sergey Brin Family Foundation, Brain and Behavior Research Foundation, and Simons Foundation to further his research.
Dr. Eshel has published articles on the behavioral roles for dopamine, serotonin, and acetylcholine; the neuroscience of irritability, depression, and addiction; LGBTQ health; and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Neuron, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and the Journal of Neuroscience, among other leading journals. He is a co-inventor on a patent for a new class of drugs for addiction, and also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.
He has delivered presentations on the neural circuits of motivated behavior, anger expression in patients with PTSD, how dopamine facilitates learning, and LGBTQ-related topics at keynotes and invited seminars in >10 countries. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Nature, Science, Neuron, Nature Communications, JAMA Psychiatry, Biological Psychiatry, and Current Biology.
Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the One Mind Rising Star Award, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, the Freedman Award (honorable mention) from the Brain and Behavior Research Foundation, the Polymath Award from Stanford's psychiatry department, and the National LGBT Health Achievement Award.
He is a member of the American Psychiatric Association, American College of Neuropsychopharmacology, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the chair of Stanford's LGBTQ+ Benefits Advocacy Committee.
Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University. -
Arvin Eslami
Research Associate, Medicine - Med/Immunology & Rheumatology
Current Role at StanfordResearch Associate in the Division of Immunology & Rheumatology at Stanford University School of Medicine.
Responsibilities include supporting immunotherapy and cellular therapy research (CAR-T and TIL), clinical data organization, database management, and contribution to manuscripts, systematic reviews, and meta-analyses.
July 2025 – Present -
Houri Esmaeilkhanian
Affiliate, Ophthalmology Research/Clinical Trials
BioDr. Esmaeilkhanian is an accomplished medical doctor who graduated from Iran University of Medical Sciences (IUMS) in 2018. Her passion for ophthalmology ignited during her medical studies, leading her to a focused research career in this field. After earning her degree, she dedicated her efforts to serving underprivileged communities while continuing her research at the Eye and Ear Research Institute of IUMS. In 2021, she advanced to the Doheny Eye Institute at UCLA, working in Prof. Vas Sadda’s lab, where she made significant contributions to research on diabetic retinopathy and age-related macular degeneration (AMD), further honing her clinical expertise. In March 2023, Dr. Esmaeilkhanian joined Byers Eye Institute, pioneering treatments for corneal injuries using innovative stem cell therapies and hydrogels. Additionally, she plays a crucial role in collaborative clinical studies involving the first FDA-approved AI device for diagnosing diabetic retinopathy impacting patient care in both the Bay Area and underserved regions.
-
Aryan Esmaeili
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
BioMy research bridges Veteran mental health, brain injury, and computational neuroscience through the development of artificial intelligence (AI), machine learning (ML), and real-world data methods to improve cognitive and rehabilitation outcomes among high-risk Veteran populations. My work focuses on the intersection of traumatic brain injury (TBI), neurodegeneration, substance use disorders, and psychiatric comorbidities, with an emphasis on understanding heterogeneous cognitive trajectories among Veterans. At the C-BRAIN Lab, I collaborate on computational approaches that integrate multimodal electronic health record (EHR) data, neuropsychological assessments, clinical narratives, and longitudinal health outcomes to better characterize cognitive impairment and recovery processes. My current research develops AI/ML phenotyping methods to distinguish potentially reversible cannabis-related cognitive impairment from progressive neurodegenerative disorders using large-scale Veterans Health Administration (VHA) data.
My long-term research goal is to advance precision rehabilitation and cognitive health strategies for Veterans with complex neurological and psychiatric conditions, including TBI and spinal cord injury (SCI). By combining computational neuroscience, causal inference methods, and patient-centered outcomes research, I aim to identify high-risk individuals earlier, improve cognitive outcome measurement, and inform more effective rehabilitation and mental health care strategies within and beyond the VA healthcare system. -
Flint Espil
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Flint Espil researches the etiology and treatment of tic disorders (including Tourette’s), Obsessive-Compulsive Disorder, and body-focused repetitive behaviors. He is interested in how psychosocial factors, the environment, and underlying brain circuitry influence treatment outcomes among individuals seeking treatment. He is also exploring ways to adapt and implement evidence-based mental health approaches in community settings. He is currently collaborating with community-based organizations in East Palo Alto to improve access to care for youth in school settings.
-
Carlos O. Esquivel, M.D., Ph.D.,FACS
Arnold and Barbara Silverman Professor in Pediatric Transplantation and Professor of Surgery (Abdominal Transplantation) and of Pediatrics (Gastroenterology, Hepatology and Nutrition)
Current Research and Scholarly Interests1) Induction of immunotolerance
2) Rejection of liver and intestinal transplantation.
3) Clinical outcomes of children with unresectable liver tumors.
